PRAX Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Praxis Precision Medicines Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 54.79 USD -0.67%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast PRAX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRAX is 141.37 USD with a low forecast of 40.4 USD and a high forecast of 283.5 USD.

PRAX Lowest Forecast

Wall Street Target

PRAX Average Forecast

Wall Street Target

PRAX Highest Forecast

Wall Street Target

26% Downside

158% Upside

417% Upside

The latest public price target was made on Mar 26, 2024 by Kambiz Yazdi from Jefferies , who expects PRAX stock to rise by 134% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Kambiz Yazdi Jefferies	128 USD Upside 134%	1 month ago Mar 26, 2024	Praxis Precision Medicines Inc. (PRAX) PT Raised to $128 at Jefferies on increases probability of success for PRAX-628 and Ulixa StreetInsider

Price Target	128 USD
Upside/Downside	134%

ABL Bio Inc

40% Upside

Hualan Biological Engineering Inc

35% Upside

Beijing Leadman Biochemistry Co Ltd

264% Upside

Shanghai Junshi Biosciences Co Ltd

29% Upside

ABL Bio Inc

40% Upside

Hualan Biological Engineering Inc

35% Upside

Beijing Leadman Biochemistry Co Ltd

264% Upside

Shanghai Junshi Biosciences Co Ltd

29% Upside

Immatics NV

77% Upside

Spero Therapeutics Inc

386% Upside

Swedish Orphan Biovitrum AB (publ)

21% Upside

Moderna Inc

16% Upside

Revenue
Forecast

The compound annual growth rate of Praxis Precision Medicines Inc's revenue for the next 3 years is 224%.

N/A

224%

N/A

N/A

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

1%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-82%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for PRAX is 141.37 USD with a low forecast of 40.4 USD and a high forecast of 283.5 USD.

The compound annual growth rate of Praxis Precision Medicines Inc's revenue for the next 3 years is 224%.

Join more than 133,500+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.